Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States.
Saved in:
| Title: | Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States. |
|---|---|
| Authors: | Baljoon A; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA., Diaby V; Independent Researcher, Gainesville, FL, 32606, USA., Suther S; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA., Dutton M; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA., Ali A; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA., Eljilany I; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, 10920 McKinley Dr., Tampa, FL, 33612, USA. islam.eljilany@hotmail.com. |
| Source: | PharmacoEconomics - open [Pharmacoecon Open] 2026 May; Vol. 10 (3), pp. 457-469. Date of Electronic Publication: 2026 Mar 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing AG Country of Publication: Switzerland NLM ID: 101700780 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-4254 (Electronic) Linking ISSN: 25094262 NLM ISO Abbreviation: Pharmacoecon Open Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41790421 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Baljoon+A%22">Baljoon A</searchLink>; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA.<br /><searchLink fieldCode="AU" term="%22Diaby+V%22">Diaby V</searchLink>; Independent Researcher, Gainesville, FL, 32606, USA.<br /><searchLink fieldCode="AU" term="%22Suther+S%22">Suther S</searchLink>; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA.<br /><searchLink fieldCode="AU" term="%22Dutton+M%22">Dutton M</searchLink>; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA.<br /><searchLink fieldCode="AU" term="%22Ali+A%22">Ali A</searchLink>; Economic, Social and Administrative Pharmacy (ESAP) Department, College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, FL, 32307, USA.<br /><searchLink fieldCode="AU" term="%22Eljilany+I%22">Eljilany I</searchLink>; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, 10920 McKinley Dr., Tampa, FL, 33612, USA. islam.eljilany@hotmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101700780%22">PharmacoEconomics - open</searchLink> [Pharmacoecon Open] 2026 May; Vol. 10 (3), pp. 457-469. <i>Date of Electronic Publication: </i>2026 Mar 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing+AG%22">Springer International Publishing AG </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101700780 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2509-4254 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225094262%22">25094262 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoecon Open <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41790421 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s41669-026-00643-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 457 Titles: – TitleFull: Cost-Utility Analysis of Faricimab Versus Aflibercept in Treating Neovascular Age-Related Macular Degeneration (nAMD) in the United States. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Baljoon A – PersonEntity: Name: NameFull: Diaby V – PersonEntity: Name: NameFull: Suther S – PersonEntity: Name: NameFull: Dutton M – PersonEntity: Name: NameFull: Ali A – PersonEntity: Name: NameFull: Eljilany I IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2509-4254 Numbering: – Type: volume Value: 10 – Type: issue Value: 3 Titles: – TitleFull: PharmacoEconomics - open Type: main |
| ResultId | 1 |
